Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
5.28 | 8986270 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
4.84 | 12718980 19131640 11954676 16100012 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
4.32 | 20046352 17594078 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
3.01 | 20889678 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
2.96 | 9014606 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
4.31 | 16780908 11298694 16823706 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
6.10 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
4.64 | 16538176 20216337 16538175 15057820 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
3.32 | 17465707 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
4.78 | 20216337 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
5.31 | 17654737 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
5.84 | 18855540 19915237 16415921 20485159 16538176 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
5.86 | 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
5.84 | 15008574 16628512 17116037 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
4.18 | 18234410 821787 17178248 19439326 17465707 19620853 7988514 9014606 20417680 19700373 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
6.01 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
5.86 | 3659116 15276670 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
6.46 | 19549232 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
6.21 | 20485159 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
5.14 | 10459572 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
5.86 | 18773962 |
MESH:D007006 |
Hypogonadism |
marker/mechanism |
|
| 19079066 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.66 | 16628512 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.84 | 9014606 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
6.21 | 20399394 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
5.49 | 16990009 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
6.21 | 17016548 |
MESH:D010146 |
Pain |
|
Carbamazepine |
4.41 | 15215642 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
6.35 | 16538176 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
6.67 | 17145499 17679678 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
5.80 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
5.63 | 9014606 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
6.46 | 9591791 12752131 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
4.08 | 9046859 9844417 16938433 16876388 15946322 19414003 16180713 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
5.86 | 19414003 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
5.86 | 15057820 19694795 19915237 18855540 16538176 16415921 20485159 |